Precision BioSciences Inc. 8-K Summary
Business Context and Reporting Period
Precision BioSciences Inc. (DTIL) filed this Current Report on Form 8-K on June 2, 2020. The company is incorporated in Delaware and trades on the Nasdaq Global Select Market. The filing serves as a Regulation FD disclosure regarding upcoming investor communications.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a procedural notice regarding presentation materials rather than a financial report.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing solely announces the company's participation in the Jefferies Virtual Healthcare Conference scheduled for June 3, 2020.
Guidance, Outlook, and Risks
The company is furnishing presentation materials (Exhibit 99.1) that will be discussed with investors and analysts. The filing explicitly states that the information in Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference into other filings except as expressly set forth.
Key Facts for Investor Verification
- Verify the content of the presentation materials (Exhibit 99.1) available on the company's Investor Relations website for any forward-looking statements or strategic updates.
- Confirm the date and time of the Jefferies Virtual Healthcare Conference presentation on June 3, 2020.
- Note that this 8-K does not provide updated financial results; refer to the most recent 10-Q or 10-K for financial data.